FDA Logo links to FDA home page
U.S. Food and Drug Administration
HHS Logo links to Department of Health and Human Services website

FDA Home Page | Dockets Home Page | Dockets Contacts and Location | Operating Status

horizonal rule

Dockets Management
Dockets Entered On December 23, 2005
Table of Contents
Docket # Title
2000P-1491 Amend Definition & Standard of Identy for Parmesan Cheese
2002N-0273 Animal Proteins Prohibited in Ruminant Feed
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
2003N-0273 Agency Information Collection Activities; Proposed Collection; Comment Request; Research Study Complaint Form
2003P-0132 Part 135 FDA regulations standard of identity frozen dessert
2005D-0356 Guidance for Industry: Questions and Answers Regarding the Final Rule on Establishment and Maintenance of Records
2005N-0150 Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of NADAs
2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
2005N-0394 FDAs Communication of Drug Safety Information; Public Hearing
2005P-0305 Remove Dietary Supplements that Contain the Drug Pyridoxamine
2005P-0420 Establish therapeutic equivalence requirements for any generic or following-on drug product referencing Adderall XR MASP
2005P-0458 Refrain from approving ANDA 77-271 until the three-year period of market exclusivity for the product has expired.
2000P-1491 Amend Definition & Standard of Identy for Parmesan Cheese
EXT 2
Attachment
European Communities Vol #: 1
2002N-0273 Animal Proteins Prohibited in Ruminant Feed
C 462 Darling International, Inc. (Darling) Vol #: 39
C 463 World Renderers Organization Vol #: 39
C 464 Food Animal Concerns Trust (FACT) Vol #: 39
C 465 Georgia Department of Agriculture Vol #: 39
C 466 National Grain and Feed Association (NGFA) Vol #: 39
C 467 Georgia Department of Agriculture Vol #: 39
C 468 M. Wise Vol #: 39
C 469 R. Kidd Vol #: 39
C 470 J. Kidd Vol #: 39
C 471 Eligible Vol #: 40
C 472 University of California Vol #: 40
C 473 Honorable Randy Neugebauer Vol #: 40
C 474 R. Martin Vol #: 40
C 475 A. Allebach Vol #: 40
C 476 Georgia Department of Agriculture Vol #: 40
C 477 Northwest Meat Processors Association Vol #: 40
C 478 Maryland Department of Agriculture Vol #: 40
C 479 B. Harris Vol #: 40
C 480 Association of American Feed Control Officials, Inc. (AAFCO) Vol #: 40
C 481 R. Biven et al. Vol #: 40
C 482 American Feed Industry Association (AFIA) Vol #: 40
C 483 Wisconsin Department of Agriculture, Trade and Consumer Protection (DATCP) Vol #: 40
C 484 County Mayor of Coffee County Vol #: 40
C 485 California Grain and Feed Association (CGFA) Vol #: 40
C 486 Consumers Union Vol #: 40
C 487 Washington State Department of Agriculture (WSDA) Vol #: 40
C 488 Griffin Industries, Inc. Vol #: 40
C 489 National Meat Association (NMA) Vol #: 40
C 490 Paul W. Brown, MD et al. Vol #: 40
C 491 C. Bremmer Vol #: 40
C 492 Food Safety and Inspection Service (FSIS) Vol #: 40
C 493 A. Bobo Vol #: 40
C 494 Kentucky Dairy Development Council (KDDC) Vol #: 40
C 495 Eligible Vol #: 40
C 496 J. Chorest Vol #: 40
C 497 Baker Commodities, Inc. Vol #: 40
C 498 Consolidated Blenders, Inc. (CBI) Vol #: 40
C 499 M. Fisher Vol #: 40
C 500 National Cattlemen's Beef Association (NCBA) Vol #: 40
C 501 Center for Food Safety (CFS) Vol #: 40
C 502 J. Longo Vol #: 40
LET 1 Honorable John E. Peterson Vol #: 40
LET 2 Honorable John E. Peterson Vol #: 40
LET 3 Honorable Jim Bunning Vol #: 40
SUP 1 Article on Spongiform Diseases Vol #: 40
2003N-0076 Food Labeling: Trans Fatty Acids in Nutrition Labeling; Consumer research to consider possible footnote statements
C 38 A. Hamburk Vol #: 10
C 39 D. Giraudo Vol #: 10
2003N-0273 Agency Information Collection Activities; Proposed Collection; Comment Request; Research Study Complaint Form
N 2 FDA Vol #: 1
2003P-0132 Part 135 FDA regulations standard of identity frozen dessert
C 18 M. Shirk Vol #: 2
C 19 A. Mattingly Vol #: 2
C 20 L. Wright Vol #: 2
C 21 No signature Vol #: 2
C 22 D. Hansen Vol #: 2
EC 33 Mr. Ben Demar Vol #: 2
EC 34 Mr. Kurt Kiebler Vol #: 2
EC 35 Mr. Dean Foss Vol #: 2
EC 36 Ms. Lori Albee Vol #: 2
EC 37 Mrs. Barbara Green Vol #: 2
EC 38 Ms. Tracy Perkins Vol #: 2
EC 39 Ms. Valerie Guinan Vol #: 2
EC 40 Mr. D Cheatham Vol #: 2
EC 41 Mrs. Claudia Whitnah Vol #: 2
EC 42 my family Vol #: 2
EC 43 Ms. Natasha Shpiller Vol #: 2
EC 44 Ms. Ellen Black Vol #: 2
EC 45 Mr. Raymond Walsh Vol #: 2
EC 46 Unemployed Farmers Vol #: 2
EC 47 Ms. Donna Gilliland Vol #: 2
EC 48 Ms. catherine sherwood Vol #: 2
EC 49 Ms. Terry Bobb Vol #: 2
EC 50 Dr. Mark Feldman Vol #: 2
EC 51 Ms. June Grade Vol #: 2
EC 52 Ms. Naomi Goldberger Vol #: 2
EC 53 Mrs. Marian Buckner Vol #: 2
EC 54 Ms. Diana Rodgers Vol #: 2
EC 55 Mr. Jim Bell Vol #: 2
EC 56 Mr. Jeremy Schneider Vol #: 2
EC 57 Dr. John McWilliams Vol #: 2
EC 58 Mr. James Showalter Vol #: 2
EXT 1 European Communities Vol #: 2
2005D-0356 Guidance for Industry: Questions and Answers Regarding the Final Rule on Establishment and Maintenance of Records
EC 2 Carolina Logistics Services, Inc. (CLS) Vol #: 1
2005N-0150 Animal Drugs, Feeds, and Related Products; Withdrawal of Approval of NADAs
NWL 1 FDA Vol #: 1
2005N-0345 Drug Approvals: Circumstances under which an active ingredient may be simultaneously marketed in both a prescription drug product and an over-the-counter drug product
C 494 G. Ziccardi Vol #: 165
C 495 M. Mingez Vol #: 165
2005N-0394 FDAs Communication of Drug Safety Information; Public Hearing
C 1 Academy of Managed Care Pharmacy (AMCP) Vol #: 2
C 2 AstraZeneca, LP Vol #: 2
2005P-0305 Remove Dietary Supplements that Contain the Drug Pyridoxamine
EC 2 Council for Responsible Nutrition Vol #: 1
EC 3 Dingwall Academy Vol #: 1
2005P-0420 Establish therapeutic equivalence requirements for any generic or following-on drug product referencing Adderall XR MASP
LET 1 Shire Pharmaceutical Group PLC Vol #: 2
2005P-0458 Refrain from approving ANDA 77-271 until the three-year period of market exclusivity for the product has expired.
PSA 1 Medi-Flex, Inc. Vol #: 1

Page created on January 18, 2006 RSC

horizonal rule

Dockets Home| Dockets Contacts and Location | Operating Status | Item Code Definitions | Federal Register
FDA Home Page | Search FDA Site | A-Z Index | Contact FDA | Privacy | Accessibility

FDA/Dockets Management